Definitive Contract W81XWH18C0082
Award Date
4/16/18
Potential Completion Date
1/15/19
Potential Value
$150K
Federal Agency
Medical Command
Awardee
Biofactura Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Biofactura Inc., a small business manufacturer, for the process development and manufacture of an antibody-based therapy against Marburgvirus. The contract is a Firm Fixed Price Definitive Contract with a ceiling value of $999,398.93 and a period of performance ending on September 14, 2022. The contract is set aside for small businesses.</p>
This is a cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Mapp Biopharmaceutical, Inc. for the development of Mapp's therapeutic intervention MBP091 as an immunotherapy for the treatment of Marburg virus infection. The contract has a ceiling value of $299,045,139.03 and a performance period ending on July 31, 2036. No set-aside was used for this award. The contract was awarded under a Broad Agency Announcement (BAA)...
This is a $149,747,956 definitive cost-no-fee contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Albert B. Sabin Vaccine Institute, Inc. to advance the development of monovalent vaccines for the prevention of Marburg virus (MARV) and Sudan ebolavirus (SUDV) disease. The contract has an ultimate completion date of September 30, 2026 and was awarded on September 26, 2019. This effort is part of BARDA's...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Mapp Biopharmaceutical, Inc., a biotechnology company based in San Diego, California. The $999,927.74 Firm Fixed Price contract is for monthly status reports related to SBIR Phase II research and development efforts. Mapp Biopharmaceutical is a key player in advancing treatments for viral hemorrhagic fevers and other emerging infectious diseases,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Antimicrobial Materials Inc., a for-profit, manufacturing organization structured as a Subchapter S corporation. The contract has a firm fixed price of $149,497.51 and was awarded on July 19, 2017 with a completion date of November 23, 2018. The contract is set aside for small businesses and is focused on research and...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
This is a $65,806,649.98 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Biofactura Inc. for preclinical and manufacturing development activities. The contract includes cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract was awarded on September 26, 2019 with an ultimate completion date of March 30, 2029. The contract has no...
<p>This is a $81,976,383.00 definitive, cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Public Health Vaccines LLC, a self-certified small disadvantaged business, for the advanced research and development of an RVSV-MARV vaccine. The contract has an ultimate completion date of August 31, 2027 and was awarded on February 1, 2019. The contract does not have a set-aside designation.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Pathovacs Inc., a minority-owned, for-profit Subchapter S corporation based in Ames, Iowa. The $149,503.95 firm-fixed-price contract is for research and development work related to the STTR (Small Business Technology Transfer) program. The contract has a completion date of August 20, 2019 and was awarded on September...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Advanced Life Technologies, LLC, a for-profit limited liability company. The contract has a firm fixed price of $149,987.71 and a completion date of April 14, 2018. The contract is for research under the SBIR program, which provides funding to small businesses for the development of innovative technologies that have potential for commercialization. The place of...